Insider · CIK 0001186801
Michael Berman
Files at NSPR (InspireMD, Inc.). First filing -, latest -.
In brief
Michael Berman files SEC Form 4 as director at NSPR (InspireMD, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael Berman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series J Warrant (right to buy)derivativeindirect: See Footnote | -30,625 | $0.00 | $0 | 30,624 | 21 d ago |
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series J Warrant (right to buy)derivativeindirect: See Footnote | +30,625 | $0.00 | $0 | 30,625 | 21 d ago |
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series K Warrant (right to buy)derivativeindirect: See Footnote | -61,248 | $0.00 | $0 | 0 | 21 d ago |
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series K Warrant (right to buy)derivativeindirect: See Footnote | +61,248 | $0.00 | $0 | 61,248 | 21 d ago |
| Jan 14, 2026 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +88,053 | $0.00 | $0 | 352,586 | Jan 16, 2026 |
| Jun 29, 2025 | NSPR InspireMD, Inc. | XIn-the-money exercise Common Stockindirect: See Footnote | +61,248 | $1.38 | $85k | 244,994 | Jul 23, 2025 |
| Jun 29, 2025 | NSPR InspireMD, Inc. | XIn-the-money exercise Series I Warrant (right to buy)derivativeindirect: See Footnote | -61,248 | $0.00 | $0 | 0 | Jul 23, 2025 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +32,491 | $0.00 | $0 | 264,533 | Jan 10, 2025 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Options to purchase common stock (right to buy)derivative | +14,836 | $0.00 | $0 | 84,950 | Jan 10, 2025 |
| Jun 24, 2024 | NSPR InspireMD, Inc. | XIn-the-money exercise Common Stockindirect: See Footnote | +61,249 | $1.38 | $85k | 183,746 | Jun 26, 2024 |
| Jun 24, 2024 | NSPR InspireMD, Inc. | XIn-the-money exercise Series H Warrant (right to buy)derivativeindirect: See Footnote | -61,249 | $0.00 | $0 | 0 | Jun 26, 2024 |
| Jan 23, 2024 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +29,032 | $0.00 | $0 | 232,042 | Jan 25, 2024 |
| Jan 23, 2024 | NSPR InspireMD, Inc. | AGrant or award Options to purchase common stock (right to buy)derivative | +11,098 | $0.00 | $0 | 70,114 | Jan 25, 2024 |
| Jan 2, 2024 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +3,782 | $0.00 | $0 | 203,010 | Jan 11, 2024 |
Questions about Michael Berman
Answered from the filings on this page, as of the latest one.
Is Michael Berman buying or selling?
Michael Berman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael Berman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Berman has 0.
Where does Michael Berman file Form 4?
Michael Berman has filed Form 4 at NSPR (InspireMD, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.